Articles related to CLINICAL STUDY

Explore the study’s analysis, which also uncovers potential cardiovascular benefits associated with SGLT2i initiation among patients with gout and type 2 diabetes.

The recent 30-year study involving folate, vitamin B6, and B12 in relation to Parkinson’s disease risk provides inconclusive evidence for the vitamins’ protective role. Further research, considering various factors like supplementation and demographic characteristics, may elucidate any potential benefits in PD prevention.

The latest systematic review on olanzapine for schizophrenia treatment has defined a therapeutic reference range of 20-40 ng/mL, offering insight into optimal efficacy and tolerable levels. Explore the full study to understand how these findings can inform clinical practice and patient care.

The study on the use of subcutaneous racemic ketamine in treatment-resistant depression underscores the significance of a flexible, individualized dosing approach over a 4-week course.

This comprehensive research highlights favorable outcomes with Cigna’s home-redirection program for pegfilgrastim administration in CIN prophylaxis, including a 32% reduction in specific complications. Explore how this study may influence future healthcare delivery models, enhancing both clinical efficacy and affordability.

The first of its kind in Cyprus, this study underscores a prevailing lack of public knowledge regarding paracetamol, including misunderstandings about its composition and concerning practices such as combining it with alcohol.